Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome

Clinical Immunology

Volumn 155, Issue 1, 2014, Pages 42-46

  Shen, Long ^b   Kapsogeorgou, Efstathia K ^a   Yu, Meixing ^b   Suresh, Lakshmanan ^c   Malyavantham, Kishore ^c   Tzioufas, Anthanasios G ^a   Ambrus, Julian L ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY AT BUFFALO   (United States)

^c IMMCO Diagnostics Inc   (United States)

Author keywords

Anti La; ; Anti Ro; ; Anti salivary gland protein 1 (SP1); Rheumatoid arthritis; ; Sjogren's syndrome;

Indexed keywords

LA ANTIBODY; PROTEIN ANTIBODY; RO ANTIBODY; SALIVARY GLAND PROTEIN 1 ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; SALIVA PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIMARY SJOGREN SYNDROME; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SECONDARY SJOGREN SYNDROME; SERUM; SJOEGREN SYNDROME; AGED; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; SALIVARY PROTEINS AND PEPTIDES; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 84907176787     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.08.009     Document Type: Article

References (19)

1. Fox R.I. Sjogren's syndrome. Lancet 2005, 366:321-331.
2. Mariette X., Gottenberg J.E. Pathogenesis of Sjogren's syndrome and therapeutic consequences. Curr. Opin. Rheumatol. 2010, 22:471-477.
3. Peri Y., Agmon-Levin N., Theodor E., Shoenfeld Y. Sjogren's syndrome, the old and the new. Best Pract. Res. Clin. Rheumatol. 2012, 26:105-117.
4. Tzioufas A.G., Kapsogeorgou E.K., Moutsopoulos H.M. Pathogenesis of Sjogren's syndrome: what we know and what we should learn. J. Autoimmun. 2012, 39:4-8.
5. Theander E., Henriksson G., Ljungberg O., Mandl T., Manthorpe R., Jacobsson L.T.H. Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann. Rheum. Dis. 2006, 65:796-803.
6. Drosos A.A., Moutsopoulos H.M. Rheumatoid arthritis in Greece: clinical, serological and genetic considerations. Clin. Exp. Rheumatol. 1995, 13(Suppl. 12):S7-S12.
7. Goules A.V., Tzioufas A.G., Moutsopoulos H.M. Classification criteria of Sjogren's syndrome. J. Autoimmun. 2014, 48-49:42-45.
8. Shen L., Suresh L., Lindemann M., Xuan J., Kowal P., Malyavantham K., et al. Novel autoantibodies in Sjogren's syndrome. Clin. Immunol. 2012, 145:251-255.
9. Jonsson R., Theander E., Sjostrom B., Brokstad K., Henriksson G. Autoantibodies present before symptom onset in primary Sjogren syndrome. JAMA 2013, 310:1854-1855.
10. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos H.M. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J. Autoimmun. 2010, 34:400-407.
11. Shen L., Suresh L., Li H., Zhang C., Kumar V., Pankewycz O., et al. IL-14alpha, the nexus for primary Sjogren's disease in mice and humans. Clin. Immunol. 2009, 130:304-312.
12. Shen L., Suresh L., Malyavantham K., Kowal P., Xuan J., Lindemann M.J., et al. Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN. J. Immunol. 2013, 191:608-613.
13. Takemoto F., Hoshino J., Sawa N., Tamura Y., Tagami T., Yokota M., et al. Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome. Am. J. Med. 2005, 118:181-184.
14. Bournia V.K., Vlachoyiannopoulos P.G. Subgroups of Sjogren syndrome patients according to serological profiles. J. Autoimmun. 2012, 39:15-26.
15. Giannouli S., Voulgarelis M. Predicting progression to lymphoma in Sjogren's syndrome patients. Expert. Rev. Clin. Immunol. 2014, 10:501-512.
16. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 2005, 5:251-262.
17. Martin D.N., Mikhail I.S., Landgren O. Autoimmunity and hematologic malignancies: associations and mechanisms. Leuk. Lymphoma 2009, 50:541-550.
18. Haga H.J., Peen E. A study of the arthritis pattern in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 2007, 25:88-91.
19. Iwamoto N., Kawakami A., Tamai M., Fujikawa K., Arima K., Aramaki T., et al. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies. J. Rheumatol. 2009, 36:113-115.